Body mass index and survival in patients with epithelial ovarian cancer

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 1, 2012, Pages 70-76

  Suh, Dong Hoon ^a   Kim, Hee Seung ^a   Chung, Hyun Hoon ^a   Kim, Jae Weon ^a   Park, Noh Hyun ^a   Song, Yong Sang ^a,b   Kang, Soon Beom ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Asian criteria; Body mass index; Epithelial ovarian cancer; Obesity; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BODY MASS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; EPITHELIAL OVARIAN CANCER; EPITHELIAL OVARY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OBESITY; OVARY CANCER; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; TREATMENT OUTCOME; UNDERWEIGHT;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BODY WEIGHT; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; OBESITY; OVARIAN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84863055474     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01628.x     Document Type: Article

References (25)

1. Kim DJ, Kwon CK, Choi DJ et al. Effects of nutritional education and exercise intervention on improvement of diet intake and metabolic risk factors in obese middle aged women. Korean J Exerc Nutr 2009; 13: 179-184.
2. Ballard-Barbash R, Swanson CA. Body weight: Estimation of risk for breast and endometrial cancers. Am J Clin Nutr 1996; 63 (3 Suppl): 437S-441S. (Pubitemid 26075827)
3. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study. BMJ 2007; 335: 1134.
4. Moon HG, Han W, Noh DY. Underweight and breast cancer recurrence and death: A report from the Korean Breast Cancer Society. J Clin Oncol 2009; 27: 5899-5905.
5. Matthews KS, Straughn JM Jr, Kemper MK, Hoskins KE, Wang W, Rocconi RP. The effect of obesity on survival in patients with ovarian cancer. Gynecol Oncol 2009; 112: 389-393.
6. Pavelka JC, Brown RS, Karlan BY et al. Effect of obesity on survival in epithelial ovarian cancer. Cancer 2006; 107: 1520-1524. (Pubitemid 44546912)
7. Chia VM, Newcomb PA, Trentham-Dietz A, Hampton JM. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer 2007; 17: 441-446. (Pubitemid 46426761)
8. Chen X, Lu W, Zheng W et al. Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat 2010; 122: 823-833.
9. Skirnisdottir I, Sorbe B. Prognostic impact of body mass index and effect of overweight and obesity on surgical and adjuvant treatment in early-stage epithelial ovarian cancer. Int J Gynecol Cancer 2008; 18: 345-351. (Pubitemid 351365212)
10. Zhang M, Xie X, Lee AH, Binns CW, Holman CD. Body mass index in relation to ovarian cancer survival. Cancer Epidemiol Biomarkers Prev 2005; 14: 1307-1310. (Pubitemid 40656486)
11. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002; 11: 822-828. (Pubitemid 35014884)
12. Munstedt K, von Georgi R, Franke FE. Effect of obesity on survival in epithelial ovarian cancer. Cancer 2007; 109: 811-812; author reply 2. (Pubitemid 46233245)
13. Calle EE, Rodriguez C,Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638. (Pubitemid 36459468)
14. Barrett SV, Paul J, Hay A, Vasey PA, Kaye SB, Glasspool RM. Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial. Ann Oncol 2008; 19: 898-902. (Pubitemid 351627304)
15. Munstedt K, Wagner M, Kullmer U, Hackethal A, Franke FE. Influence of body mass index on prognosis in gynecological malignancies. Cancer Causes Control 2008; 19: 909-916.
16. Hess LM, Barakat R, Tian C, Ozols RF, Alberts DS. Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 2007; 107: 260-265. (Pubitemid 47575723)
17. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
18. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
19. Holschneider CH, Berek JS. Ovarian cancer: Epidemiology, biology, and prognostic factors. Semin Surg Oncol 2000; 19: 3-10. (Pubitemid 30439309)
20. Modesitt SC, van Nagell JR, Jr. The impact of obesity on the incidence and treatment of gynecologic cancers: A review. Obstet Gynecol Surv 2005; 60: 683-692. (Pubitemid 41368535)
21. Papadia A, Ragni N, Salom EM. The impact of obesity on surgery in gynecological oncology: A review. Int J Gynecol Cancer 2006; 16: 944-952.
22. Fujinaga A, Fukushima Y, Kojima A et al. Anesthetic management of an extremely obese patient. J Anesth 2007; 21: 261-264. (Pubitemid 46692020)
23. Kim HY, Kim JW, Kim SH, Kim YT, Kim JH. An analysis of the risk factors and management of lymphocele after pelvic lymphadenectomy in patients with gynecologic malignancies. Cancer Res Treat 2004; 36: 377-383.
24. Salman MC, Usubutun A, Ozlu T, Boynukalin K, Yuce K. Obesity does not affect the number of retrieved lymph nodes and the rate of intraoperative complications in gynecologic cancers. J Gynecol Oncol 2010; 21: 24-28.
25. Heintz AP, Odicino F, Maisonneuve P et al. Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006; 95 (Suppl. 1): S161-S192.